LifeMD, Inc.: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Aug 14, 2017 and accepted by EDGAR at Aug 14, 2017, 16:27 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-04-01 to 2017-06-30 | $1.1m | us-gaap:Revenues |
| Revenue | 6 months2017-01-01 to 2017-06-30 | $1.5m | us-gaap:Revenues |
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $329.2k | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2017-01-01 to 2017-06-30 | $532.6k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2017-04-01 to 2017-06-30 | $778.2k | us-gaap:GrossProfit |
| Gross profit | 6 months2017-01-01 to 2017-06-30 | $999.3k | us-gaap:GrossProfit |
| Operating income | 3 months2017-04-01 to 2017-06-30 | −$225.5k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | −$600.5k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-04-01 to 2017-06-30 | $250 | us-gaap:InterestExpense |
| Interest expense | 6 months2017-01-01 to 2017-06-30 | $649.6k | us-gaap:InterestExpense |
| Net income | 3 months2017-04-01 to 2017-06-30 | $737.5k | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | −$307.3k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | $0.02 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | $0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | −$0.01 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 47,254,218 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 39,224,839 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2017-01-01 to 2017-06-30 | −$512.6k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2017-06-30 | $436.1k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $1.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $1.2m | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $1.6m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2017-06-30 | −$149.4k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-17-008664. Last ingested by Listed: Nov 13, 2026, 16:33 ET. Listed shows no prices and gives no investment advice.